The collaboration will facilitate the use of Scope’s visual recognition and annotation technology in a variety of applications. Credit: PeopleImages.com – Yuri A/Shutterstock.

Scope Technologies has signed a letter of intent (LOI) with Global Care Innovations (GCI) and BitLab to deliver quantum-secure data solutions and AI-driven tools to North American healthcare providers.

Under this partnership, GCI will license the QSE range of quantum-resistant encryption and decentralised storage solutions from Scope.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

This is intended to provide healthcare organisations with HIPAA-compliant and secure data management.

BitLab is set to become the main development collaborator, leveraging the visual recognition and neural network technologies of Scope to produce bespoke AI applications

Scope Technologies CEO James Young said: “This partnership with GCI and BitLab marks a significant step forward in our mission to secure sensitive health information against both current and future cyber threats.

“Our collaboration combines robust quantum security with innovative AI solutions, empowering healthcare providers to protect patient data while improving diagnostics and treatment options through advanced AI.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The partnership will enable Scope’s visual recognition and annotation technology to be used across a range of applications.

These applications encompass AI-driven diagnostic tools and tailored treatment recommendations.

Scope’s technology offers a scalable basis for different innovations in healthcare, all underpinned by quantum-secure data storage to guarantee the safety of patient information.

In terms of quantum security, GCI plans to incorporate Scope’s QSE platform to deliver quantum-resistant data backups and secure individual patient data vaults, with the goal of achieving or surpassing regulatory data protection standards.

GCI CEO Dr Ragui Ibrahim said: “Scope’s technology aligns perfectly with our vision of transforming healthcare through AI-driven solutions and secure data management. This partnership enables us to expand our offerings to healthcare providers, ensuring that data is safeguarded both today and as we move into a quantum-powered future.”

The finalisation of the transaction is contingent upon the parties entering into a definitive agreement.